STEPAN (SCL)
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Materials
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for SCL
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| SCL | Director | 63 | ["Vice President, Finance and Chief Financial Officer, Americas Region of Medtronic Inc.", "25 years at Medtronic", "financial expertise", "broad operational and strategic experience"] | [] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ANGO | Director | 63 | ["Former Chief Financial Officer and Vice President of Finance", "Served as CFO and VP of Finance for the Americas Region at Medtronic, Inc.", "Experience with financial, business and strategic issues in a diversified medical device company", "Bachelor of Arts in Communication and Political Science from the University of Michigan", "Master's in Business Administration from Ohio State University"] | ["Audit Committee", "Compensation Committee"] | 2025 |
Biography sourced from the proxy statement filing.
Vice President, Finance and Chief Financial Officer, Americas Region of Medtronic Inc., a medical technology company, from March 2015 through June 2023. Director of AngioDynamics, Inc. (NASDAQ: ANGO). Ms. Burgess spent 25 years at Medtronic and retired as a regional chief financial officer. She provides the Board of Directors with financial expertise and with broad operational and strategic experience developed throughout her career in a range of financial leadership roles.